PDUFA extended till Septemberhttp://www.marketwatch.com/story/ironwood-and-forest-announce-fda-has-extended-the-review-period-for-linaclotide-to-september-2012-2012-04-23
What's the chance that this drug will not get approved by the FDA? Are the analysts optimistic? Are they giving it greater than a 50% chance of approval?Based on the data I have seen, it seems an approval is eminent... Any thoughts?I am looking at buying and would love to hear any opinions, good or bad. Thanks.
Approval is likely. The latest FDA decision date is September. Listen to recent webcast -- link is on IRWD website.FYO: the word is "imminent" not "eminent"
Given the recent pull back due to the PDUFA date being delay 90 days, it seems to me that $12ish is a good entry point...Anyone agree?